APA (7th ed.) Citation

Hofmann, J., Bartůněk, A., Hauser, T., Sedmak, G., Beránek, J., Ryšánek, P., . . . Slanař, O. (2023). Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans. Leukemia, 37(12), 2486-2492. https://doi.org/10.1038/s41375-023-02045-1

Chicago Style (17th ed.) Citation

Hofmann, Jiří, Aleš Bartůněk, Tomáš Hauser, Gregor Sedmak, Josef Beránek, Pavel Ryšánek, Martin Šíma, and Ondřej Slanař. "Dasatinib Anhydrate Containing Oral Formulation Improves Variability and Bioavailability in Humans." Leukemia 37, no. 12 (2023): 2486-2492. https://doi.org/10.1038/s41375-023-02045-1.

MLA (9th ed.) Citation

Hofmann, Jiří, et al. "Dasatinib Anhydrate Containing Oral Formulation Improves Variability and Bioavailability in Humans." Leukemia, vol. 37, no. 12, 2023, pp. 2486-2492, https://doi.org/10.1038/s41375-023-02045-1.